Bing Li

Statistics

Publications

Citations

H-Index

Active since

2015

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Bing Li is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, hit-to-lead progression, and structure-activity relationships.

ORCID

Publications per year

2015–2016

Publications

Expression of TSLP and Downstream Molecules IL-4, IL-5, and IL-13 on the Eye Surface of Patients with Various Types of Allergic Conjunctivitis

Xiaofen Zheng, Juan Yao, Bing Li · Journal of Ophthalmology · 2016 · 23 citations · Full text

Medicine, Immunology, Ophthalmology +17

Rapid development of two factor IXa inhibitors from hit to lead

Dann L. Parker, Shawn P. Walsh, Bing Li et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 18 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

1–2 of 2